| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |